Future Directions in Cardiac Amyloidosis
Just a few years ago, cardiac amyloidosis (CA) was rarely diagnosed. With poor treatment options and delayed and infrequent diagnoses, most patients who were eventually recognized to have CA were referred for hospice care. Now, the availability of sponsored genetic testing, increased use of nuclear...
Saved in:
| Main Author: | Barry Trachtenberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2022-03-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1071 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis
by: Alessia Argirò, et al.
Published: (2025-04-01) -
Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery
by: Joanna Waś, et al.
Published: (2025-07-01) -
Cardiac amyloidosis in the practice of a cardiologist and therapist. Case report
by: T. V. Nikiforova, et al.
Published: (2025-01-01) -
Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data
by: Maximilian Leo Müller, et al.
Published: (2024-07-01) -
Echocardiographic features of amyloid cardiomyopathy phenotypes in patients with different types of amyloidosis
by: Olga Ya. Сhaikovskaya, et al.
Published: (2025-01-01)